Literature DB >> 26879423

Exploration of the serum metabolite signature in patients with rheumatoid arthritis using gas chromatography-mass spectrometry.

Jia Zhou1, Jiao Chen1, Changfeng Hu1, Zhijun Xie1, Haichang Li1, Shuangshuang Wei1, Dawei Wang1, Chengping Wen2, Guowang Xu3.   

Abstract

Rheumatoid arthritis (RA) is a systemic autoimmune disease with complicated pathogeny. There could be obvious alterations of metabolism in the patients with RA and the discovery of metabolic signature may be helpful for the accurate diagnosis of RA. In order to explore the distinctive metabolic patterns in RA patients, a gas chromatography-mass spectrometry (GC-MS) method was employed. Serum samples from 33 RA patients and 32 healthy controls were collected and analyzed. Acquired metabolic data were assessed by the principal component analysis (PCA) and partial least squares discriminant analysis (PLS-DA), and the data analysis results showed RA patients and healthy controls have very different metabolic profiles. Variable importance for project values (VIP) and Student's t-test were combined to screen the significant metabolic changes caused by RA. Serums from RA patients were featured by decreased levels of amino acids and glucose, increased levels of fatty acids and cholesterol, which were primarily associated with glycolytic pathway, fatty acid and amino acid metabolism, and other related pathways including TCA cycle and the urea cycle. These preliminary results suggest that GC-MS based metabolic profiling study appears to be a useful tool in the exploration of the metabolic signature of RA, and the revealed disease-associated metabolic perturbations could help to elucidate the pathogenesis of RA and provide a probable aid for the accurate diagnosis of RA.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Disease-associated metabolites; GC–MS; Metabolomics; Rheumatoid arthritis; Serum

Mesh:

Substances:

Year:  2016        PMID: 26879423     DOI: 10.1016/j.jpba.2016.02.004

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  34 in total

Review 1.  Immunometabolism in early and late stages of rheumatoid arthritis.

Authors:  Cornelia M Weyand; Jörg J Goronzy
Journal:  Nat Rev Rheumatol       Date:  2017-03-31       Impact factor: 20.543

2.  Circulating plasma metabolites and risk of rheumatoid arthritis in the Nurses' Health Study.

Authors:  Su H Chu; Jing Cui; Jeffrey A Sparks; Bing Lu; Sara K Tedeschi; Cameron B Speyer; LauraKay Moss; Marie L Feser; Lindsay B Kelmenson; Elizabeth A Mewshaw; Jess D Edison; Kevin D Deane; Clary Clish; Jessica Lasky-Su; Elizabeth W Karlson; Karen H Costenbader
Journal:  Rheumatology (Oxford)       Date:  2020-11-01       Impact factor: 7.580

3.  LC-MS-based serum metabolomics reveals a distinctive signature in patients with rheumatoid arthritis.

Authors:  Ju Li; Nan Che; Lingxiao Xu; Qian Zhang; Qi Wang; Wenfeng Tan; Miaojia Zhang
Journal:  Clin Rheumatol       Date:  2018-02-13       Impact factor: 2.980

4.  Serum metabolite differences detected by HILIC UHPLC-Q-TOF MS in systemic sclerosis.

Authors:  Chen Sun; Huimin Zhu; Yun Wang; Yichen Han; Dongdong Zhang; Xi Cao; Mihribangvl Alip; Min Nie; Xue Xu; Liangjing Lv; Xuebing Feng; Lingyun Sun; Dandan Wang
Journal:  Clin Rheumatol       Date:  2022-09-20       Impact factor: 3.650

Review 5.  Membrane fatty acid desaturase: biosynthesis, mechanism, and architecture.

Authors:  Nur Farah Anis Abd Halim; Mohd Shukuri Mohamad Ali; Adam Thean Chor Leow; Raja Noor Zaliha Raja Abd Rahman
Journal:  Appl Microbiol Biotechnol       Date:  2022-09-05       Impact factor: 5.560

Review 6.  Metabolic Profiling in Rheumatoid Arthritis, Psoriatic Arthritis, and Psoriasis: Elucidating Pathogenesis, Improving Diagnosis, and Monitoring Disease Activity.

Authors:  Erika Dorochow; Michaela Köhm; Lisa Hahnefeld; Robert Gurke
Journal:  J Pers Med       Date:  2022-06-02

7.  Analysis of brain metabolites by gas chromatography-mass spectrometry reveals the risk-benefit concerns of prednisone in MRL/lpr lupus mice.

Authors:  Jia Zhou; Feilong Lu; Shan Li; Meijuan Xie; Haimei Lu; Zhijun Xie; Dehong Wu; Shuang Wang; Chengping Wen; Zheng-Hao Xu
Journal:  Inflammopharmacology       Date:  2019-11-30       Impact factor: 4.473

8.  Metabolomic profile overlap in prototypical autoimmune humoral disease: a comparison of myasthenia gravis and rheumatoid arthritis.

Authors:  Derrick Blackmore; Liang Li; Nan Wang; Walter Maksymowych; Elaine Yacyshyn; Zaeem A Siddiqi
Journal:  Metabolomics       Date:  2020-01-04       Impact factor: 4.290

Review 9.  Mixing omics: combining genetics and metabolomics to study rheumatic diseases.

Authors:  Cristina Menni; Jonas Zierer; Ana M Valdes; Tim D Spector
Journal:  Nat Rev Rheumatol       Date:  2017-02-02       Impact factor: 20.543

10.  Up-regulated microRNA-411 or declined RIPK1 inhibits proliferation and promotes apoptosis of synoviocytes in rheumatoid arthritis mice via decreased NF-κB pathway.

Authors:  Yijiang Huang; Kaizhe Chen; Huachen Yu; Daosen Chen; Lianfu Deng; Yu Zhang; Xinghe Xue; Xiaoyun Pan
Journal:  Cell Cycle       Date:  2020-03-01       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.